دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Long COVID: understanding the neurological effects
doi : 10.1016/S1474-4422(21)00059-4
Volume 20, Issue 4, April 2021, Page 247
Blood pressure management after endovascular therapy
Wendy CZiaiaMaisAl-Kawaza
doi : 10.1016/S1474-4422(21)00058-2
Volume 20, Issue 4, April 2021, Pages 248-249
Preventing expensive harms in Guillain-Barré syndrome
Michael PLunna
doi : 10.1016/S1474-4422(21)00041-7
Volume 20, Issue 4, April 2021, Pages 249-251
Gene therapy for spinal muscular atrophy: hope and caution
NathalieGoemansa
doi : 10.1016/S1474-4422(21)00071-5
Volume 20, Issue 4, April 2021, Pages 251-252
Cerebral microbleeds and prediction of intracranial haemorrhage
Steven MGreenberga
doi : 10.1016/S1474-4422(21)00065-X
Volume 20, Issue 4, April 2021, Pages 252-254
Brain network reorganisation in an adolescent after bilateral perinatal strokes
Timothy OLaumannacMarioOrtegaaCatherine RHoytafNicole ASeidera,Brain Network Platicity Group†Abraham ZSnyderabNico UFDosenbachabde
doi : 10.1016/S1474-4422(21)00062-4
Volume 20, Issue 4, April 2021, Pages 255-256
Inspiring the next generation
Conor SGillespieaSohamBandyopadhyaybAlistair JJenkinscPeterHutchinsondeThe Neurology and Neurosurgery Interest Group
doi : 10.1016/S1474-4422(21)00068-5
Volume 20, Issue 4, April 2021, Pages 256-257
Computational neuroscience with global accessibility
AnnaSadnickaabLydiaMardellbSvenBestmannb
doi : 10.1016/S1474-4422(21)00074-0
Volume 20, Issue 4, April 2021, Pages 257-258
Correction to Lancet Neurology 2021; 19: 1033–42
doi : 10.1016/S1474-4422(21)00039-9
Volume 20, Issue 4, April 2021, Page e3
Correction to Lancet Neurology 2021; 20: 235–46
doi : 10.1016/S1474-4422(21)00069-7
Volume 20, Issue 4, April 2021, Page e3
Maria Rodr?guez-Oroz: leading the research to prevent cognitive decline in Parkinson's disease
TonyKirby
doi : 10.1016/S1474-4422(20)30481-6
Volume 20, Issue 4, April 2021, Page 259
What astrocytes need to do
Giles EHardinghamGabor CPetzoldArpan RMehta
doi : 10.1016/S1474-4422(21)00070-3
Volume 20, Issue 4, April 2021, Page 260
An artist and his wife, the artist
JulesMorgan
doi : 10.1016/S1474-4422(20)30480-4
Volume 20, Issue 4, April 2021, Page 261
Parkinson's disease in traditional Chinese medicine
SongLiWeidongLe
doi : 10.1016/S1474-4422(19)30224-8
Volume 20, Issue 4, April 2021, Page 262
Licence to practise
AravinthanVaratharaj
doi : 10.1016/S1474-4422(20)30403-8
Volume 20, Issue 4, April 2021, Page 263
Smart homes for the future of dementia care
JonathanBlott
doi : 10.1016/S1474-4422(19)30249-2
Volume 20, Issue 4, April 2021, Page 264
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial
ProfMikaelMazighiMDaeghProfSebastienRichardMDijBertrandLapergueMDkProfIgorSibonMDmProfBenjaminGoryMDnoJeromeBergeMDpArturoConsoliMDlJulienLabreucheBSTqProfJean-MarcOlivotMDrProfJosephBroderickMDsProfAlainDuhamelPhDqProfEmmanuelTouzeMDtProfAdnan IQureshiMDuAmélieYavchitzMDbSimonEscalardMDaJean-PhilippeDesillesMDaeghHocineRedjemMDaStanislasSmajdaMDa…SharmilaSagnier
doi : 10.1016/S1474-4422(20)30483-X
Volume 20, Issue 4, April 2021, Pages 265-274
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
ChristaWalgaardMDaProfBart CJacobsMDabHester FLingsmaPhDcProfEwout WSteyerbergPhDcdBiancavan den BergMDafAlexandra YDoetsMDaSonja ELeonhardMDaChristineVerboonMDaRuthHuizingaPhDbJudithDrenthenMDaSamuelArendsMDaIlona KleineBuddePhDgRuud PKleywegMDhKristaKuitwaardMDahMarjon F Gvan der MeulenMDiJohnny P ASamijnMDjFrederique HVermeijMDkProfJan B MKuksMDl…R.Trip
doi : 10.1016/S1474-4422(20)30494-4
Volume 20, Issue 4, April 2021, Pages 275-283
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
ProfJohn WDayMDaProfRichard SFinkelMDbcProfClaudia AChiribogaMDdProfAnne MConnollyMDefghProfThomas OCrawfordMDijProfBasil TDarrasMDkProfSusan TIannacconeMDlProfNancy LKuntzMDmLoren D MPe?aMDnoPerry BShiehMDpEdward CSmithMDqProfJennifer MKwonMDrCraig MZaidmanMDsMeredithSchultzMDuDouglas EFeltnerMDuSitraTauscher-WisniewskiMDuHaojunOuyangPhDuDeepa HChandMDtu…ProfJerry RMendellMDfgh
doi : 10.1016/S1474-4422(21)00001-6
Volume 20, Issue 4, April 2021, Pages 284-293
Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
Jonathan GBestMDaGarethAmblerPhDbDuncanWilsonPhDacKeon-JooLeeMDdJae-SungLimMDeMasayukiShiozawaMDfMasatoshiKogaMDfLinxinLiDPhilgCarolineLovelockFRACPgProfHuguesChabriatMDhijProfMichaelHennericiMDkYuen KwunWongMSclHenry Ka FungMakMDmLuisPrats-SanchezPhDnAlejandroMart?nez-Dome?oMDnShigeruInamuraMDpKazuhisaYoshifujiPhDpEthem MuratArsavaMDq…JohnMitchell
doi : 10.1016/S1474-4422(21)00024-7
Volume 20, Issue 4, April 2021, Pages 294-303
Menstrual migraine: a distinct disorder needing greater recognition
Kjersti Gr?ttaVetvikPhDaProfE AnneMacGregorMDb
doi : 10.1016/S1474-4422(20)30482-8
Volume 20, Issue 4, April 2021, Pages 304-315
Epilepsy in China: major progress in the past two decades
ProfDingDingPhDa†ProfDongZhouPhD†bProfJosemir WSanderFRCPcdeProfWenzhiWangMDfProfShichuoLiMDgProfZhenHongMDa
doi : 10.1016/S1474-4422(21)00023-5
Volume 20, Issue 4, April 2021, Pages 316-326
